Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma

Clinical trial NCT00441883 · COMPLETED

Trial details

NCT number: NCT00441883
Sponsor: Bausch & Lomb Incorporated
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Open Angle Glaucoma Ocular Hypertension Pigmentary Glaucoma Pseudoexfoliative Glaucoma

Start date: 2007-03-01
Primary completion: 2008-02-01
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.